Skip to content
HOME
TEAM
RESEARCH
Unveiling the Role of Gut Microbiota in MAFLD Pathogenesis
Gut Microbiota and MASH/Fibrosis Resolution after Bariatric Surgery
Evaluation of the Epigenome, Microbiome, and Metabolome Dynamics
Epitranscriptomic Analysis in Patients with MASLD/MASH
PROJECTS
PUBLICATIONS
NEWS
CONTACT
Loading...
RESEARCH
RESEARCH
MetaObesity Lab
2021-09-10T19:09:34+02:00
Research Lines
OUR LABORATORY IS CURRENTLY WORKING ON 3 MAIN ACTIVE RESEARCH LINES.
Unveiling the role of gut microbiota and epigenetic alterations in the pathogenesis of non-alcoholic fatty liver disease (NAFLD)
Gut microbiota and related metabolites as potential markers of non-alcoholic steatohepatitis (NASH) resolution after bariatric surgery
Gut microbiome modification through dietary intervention in patients with colorectal cancer (CRC) and response to surgery
Page load link
Go to Top